1. Home
  2. AROW vs IRWD Comparison

AROW vs IRWD Comparison

Compare AROW & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$41.05

Market Cap

663.5M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.13

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
IRWD
Founded
1851
1998
Country
United States
United States
Employees
578
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
663.5M
663.6M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
AROW
IRWD
Price
$41.05
$4.13
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$28.00
$7.67
AVG Volume (30 Days)
75.7K
1.9M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
3.33%
N/A
EPS Growth
49.72
1400.00
EPS
0.82
0.24
Revenue
N/A
$298,276,000.00
Revenue This Year
$33.36
$57.95
Revenue Next Year
$18.26
$4.39
P/E Ratio
$48.95
$16.00
Revenue Growth
N/A
8.88
52 Week Low
$25.84
$0.67
52 Week High
$40.54
$5.78

Technical Indicators

Market Signals
Indicator
AROW
IRWD
Relative Strength Index (RSI) 65.29 60.83
Support Level $35.26 $3.80
Resistance Level $40.29 $4.50
Average True Range (ATR) 1.08 0.22
MACD 0.16 0.07
Stochastic Oscillator 83.45 94.05

Price Performance

Historical Comparison
AROW
IRWD

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: